Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. The company's focus is enabling the full therapeutic potential of next-generation sGC stimulators. sGC stimulators are small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate, or cGMP. cGMP is a key second messenger that, when produced by sGC, regulates diverse and critical biological functions throughout the body including blood flow and vascular dynamics, inflammatory and fibrotic processes, metabolism and neuronal function.

Nicholas Financial is a holding company. Through its subsidiary, Nicholas Financial, Inc., the company is engaged primarily in acquiring and servicing automobile finance installment contracts (Contracts) for purchases of used and new automobiles and light trucks. In addition, the company also originates direct consumer loans (Direct Loans) and sells consumer-finance related products. For Automobile Finance Business - Contracts, the company is engaged in the business of providing financing programs, on behalf of purchasers of used cars and light trucks. For Contract Procurement, the Contracts purchased by the company is for used vehicles. For Direct Loans, the loans originated directly between the company and the consumer.

Verrica Pharmaceuticals is a dermatology therapeutics company focused on the development and commercialization of treatments for people living with skin diseases. The company's primary product candidate, VP-102, is a proprietary drug-device combination of its topical solution of cantharidin, a naturally sourced agent to treat topical dermatological conditions, administered through its single-use precision applicator. The company is initially developing VP-102 for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. In addition, the company is also developing VP-102 for the treatment of external genital warts.

Vishay Precision Group is a designer, manufacturer and marketer of sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages. The company provides precision products and solutions, engaging in the markets of stress, force, weight, pressure, and current measurements. Force Sensors, which includes a line of load cells and force measurement transducers that are provided as precision sensors for industrial and commercial use; and Weighing and Control Systems, which designs and manufactures systems comprised of load cells and instrumentation for weighing and force control/measurement for a variety of uses, including on-board weighing and overload monitor systems.

WillScot is a holding company. Through its subsidiaries, the company is engaged in providing modular space and portable storage solutions. The company leases modular space and portable storage units to customers in the commercial and industrial, construction, education, energy and natural resources, government and other end-markets. The company's modular space products and services include panelized and stackable offices, single-wide modular space units, section modulars and redi-plex, classrooms, container offices, other modular space. The company's portable storage products and services include value-added products and services and delivery, installation and removal.